Business »  Topic »  Top Headlines: Relief for pharma cos, ban to hit Chinese firms, and more

Top Headlines: Relief for pharma cos, ban to hit Chinese firms, and more


Message: Recipients' Email: Type address separated by commas
Your Email: Enter the characters shown in the image.
Send me a copy:

https://mybs.in/2YOe5ZI

After representations from industry bodies, the government on Tuesday cleared imports of active pharma ingredients (APIs) from China. The Kishore Biyani-led Future group has zeroed in on SBI General to sell its majority stake in the general insurance joint venture, and on Premji Invest for its life insurance venture stake. Here are the top headlines on Wednesday morning.

Relief for pharma firms

Easing restrictions on imports from China, the Customs department has decided to clear ...


Read the full text business-standard